Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2

Abstract

The Omicron variant (B.529) of COVID-19 caused disease outbreaks worldwide because of its contagious and diverse mutations. To reduce these outbreaks, therapeutic drugs and adjuvant vaccines have been applied for the treatment of the disease. However, these drugs have not shown high efficacy in reducing COVID-19 severity, and even antiviral drugs have not shown to be effective. Researchers thus continue to search for an effective adjuvant therapy with a combination of drugs or vaccines to treat COVID-19 disease. We were motivated to consider melatonin as a defensive agent against SARS-CoV-2 because of its various unique properties. Over 200 scientific publications have shown the significant effects of melatonin in treating diseases, with strong antioxidant, anti-inflammatory, and immunomodulatory effects. Melatonin has a high safety profile, but it needs further clinical trials and experiments for use as a therapeutic agent against the Omicron variant of COVID-19. It might immediately be able to prevent the development of severe symptoms caused by the coronavirus and can reduce the severity of the infection by improving immunity.

Strictinin, a Major Ingredient in Yunnan Kucha Tea Possessing Inhibitory Activity on the Infection of Mouse Hepatitis Virus to Mouse L Cells

“…Therefore, natural compounds in herbs seem to be rich sources for screening potential drugs against coronaviruses. As expected, several herbal medicines as well as isolated compounds in herbs have been reported to possess inhibitory activities against SARS-CoV-2 in the past few years [ 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 ]. Although herbal medicines and their isolated compounds are not as effective as chemical antiviral drugs, they are empirically safe for the human body, particularly after long-term consumption.…”

Circadian rhythm in systemic autoimmune conditions: Potential of chrono-immunology in clinical practice: A narrative review

“…Melatonin levels vary throughout the day, with low levels during daytime and a peak at night. [91,92] In addition to its role in modulating sleep, learning, and memory, melatonin acts as a neuroprotective factor in the central nervous system www.md-journal.com by activating melatonin (MT)1 and MT2 receptors, both of which are G-protein coupled receptors (Figs. 2 and 3).…”

Spiroindole-containing compounds bearing phosphonate group of potential Mpro-SARS-CoV-2 inhibitory properties

“…Reports supported that treatment of COVID-19 patients with melatonin alone or in combination with another therapeutic drug either shortened the hospitalization period or reduced the severity of the viral infection ( Fig. 2 ) [ [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] ].…”